SullivanM. Live attenuated nasal flu vaccine best for ages 2-8. Pediatr News. 2014;48:1, 4.
2.
BelsheRBEdwardsKMVesikariT; CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356:685-696.
3.
BergenRBlackSShinefieldH. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J. 2004;23:138-144.
4.
AmbroseCSDubovskyFYiTBelsheRBAshkenaziS. The safety and efficacy of live attenuated vaccine in young children with asthma or prior wheezing. Eur J Clin Microbiol Infect Dis. 2012;31:2549-2557.
5.
VesikariTKarvonenAKorhonenT; CAIV-T Transmission Study Group. A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine. Pediatr Infect Dis J. 2006;25:590-595.
6.
AmbroseCSLevinMJBelsheRB. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza Other Respir Viruses. 2010;5:67-75.
